6[3]Rein Ms,Barbieri RL,Friedman AJ.Progesterone:a critical role in the pathogenesis of uterine myomas.Am J Obstet Gynecol,1995,172:14
7[4]Murphy AA,Kettel LM,Morales AJ,et al.Regression of uterine leiomyoma in response to antiprogestin mifepristone.J Clin Endocrinol Metab,1993,76:513
8[9]Reinsch RC,Murphy AA,Morales AJ,et al.The effects of RU486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus:a prospective,randomized study.Am J Obstet Gynecol,1994,170:1623
9[10]Stovall TG.GnRH-a utilization before hysterectomy.Clin Obstet Gynecol,1993,36:642
10Dueholm M. Forman A, Ingerslev J. Regression of residual tissue after implete resection of submucous myomas. Gynecol Endos 1998,7:309~314.
2Ludovico Muzii, Terenzio Boni. GnRH analogue treatment before hysteroscopic resection of submucous myomas: A prospective, randomized, multicenter study[J]. Fertil Steri1,2010,94 : 1496-1499.
3夏思兰 FelixWong 李白新.妇科内镜学[M].北京:人民卫生出版社,2001.5..
4Zhang Y, Sun L, Guo Y, et al. The impact of preoperative Gonadotropin-releasing hormone agonist treatment on women with uterine fibroids : a meta- analysis [ J ]. Obstet Gynecol Surv, 2014, 69 (2): 100-108.
5Kim M D, Lee M, Lee M S, et al. Uterine artery embolization of large fibroids: comparative study of procedure with and without pretreatment gonadotropin-releasing hormone agonists [J]. MR Roentgenol, 2012, 199 (2) : 441-446.
6Chu CM, Dabney L, Hardart A. Treatment of urinary retention caused by uterine leiomyoma with a gonadotropin- releasing hormone agonist: case report and review [J]. Female Pelvic Med Reconstr Surg, 2013, 19 (1) : 52-55.
7Bosch E, Labarta E, Crespo J, et al. Impact of luteinizing hormone administration on gonadotropin- releasing hormone antagonist cycles: an age- adjusted analysis [ J]. Fertil Steril, 2011, 95 (3): 1031-1036.
8Talaulikar VS, Manyonda IT. Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids [J]. AdvTher, 2012, 29 (8):655-663.
9Jasonni VM, D "Anna R, Mancuso A, et al. Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra - operative blood loss of different length of leuprolide acetate depot treatment before myomectomy [J]. Acta Obstet Gynecol Scand, 2001, 80 (10) : 956-958.
10Watanabe Y, Nakamura G, Matsuguchi H, et al. Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women [ J]. Fertil Steril, 1992, 58 (1) : 66-71.